NEW YORK (GenomeWeb News) – Scripps Center for Executive Health will offer Pathway Genomics' genetic tests to patients through Scripps Health's network of physicians, clinics, hospitals, and other healthcare organizations.

San Diego-based Pathway said that Scripps would offer its genetics tests for diet, nutrition, and exercise response, as well as tests that point to the risk of developing serious diseases, such as heart disease, type 2 diabetes, and common cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.